Who
Christopher M. Murphy
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, AnaptysBio; Chief Financial & Bus. Officer, Third Harmonic Bio.
In numbers
- Trades disclosed
- 7
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 5 Jan 2024
- Last trade
- 11 May 2026
- Last filed
- 13 May 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 May 2026filed 13 May 2026 | ANAB AnaptysBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —25,765 at $0.00 | filing |
| 11 May 2026filed 13 May 2026 | ANAB AnaptysBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —25,765 at $0.00 | filing |
| 11 Aug 2025filed 14 Aug 2025 | Third Harmonic Biooption or derivative | SEC FORM 4 Code J | —47,500 at $0.00 | filing |
| 1 Mar 2025filed 5 Mar 2025 | Third Harmonic Biooption or derivative | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 15 Jan 2025filed 17 Jan 2025 | Third Harmonic Biooption or derivative | SEC FORM 4 Code A | —140,000 at $0.00 | filing |
| 15 Jan 2025filed 17 Jan 2025 | Third Harmonic Biooption or derivative | SEC FORM 4 Code A | —17,500 at $0.00 | filing |
| 5 Jan 2024filed 9 Jan 2024 | Third Harmonic Biooption or derivative | SEC FORM 4 Code A | —410,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.